Healthy Life for Mankind
Opening a new world of in silico drug discovery
Galux revolutionizes drug discovery with an integrated in silico technology which combines physics, chemistry, and artificial intelligence.
Galux is based on protein structure modeling platform "GALAXY", which has been proven to be one of the best methods in the world in a blind experiment with competitors such as CASP and CAPRI.
Structure-based in silico drug design
Galux has the technology to rationally design drug molecules based on the protein structures in silico.
Galux integrates physics, chemistry and the artificial intelligence technologies to design new drug molecules.
Protein drug design
Protein–protein interactions (PPIs) are increasingly being targeted by pharmaceutical companies. Galux has a specialized software to predict protein-protein interaction , which can be used to design new protein drugs efficiently. Galux's protein-protein interaction prediction method showed outstanding performance in CAPRI international competitions.
Peptide drug design
Protein-peptide interaction prediction method in Galux enables accurate prediction of protein-peptide complex structure and binding affinity. Peptide and peptidomimetic drugs can be rationally designed using our software. Galux's protein-peptide interaction prediction method showed outstanding performance in CAPRI international competitions.
Small molecule drug design
Galux small-molecule drug design software is built on prediction of atomistic interactions of protein and small molecules by physics-inspired deep learning methods. Galux protein-ligand interaction showed outstanding performances in international competitions such as GPCRDock and CSAR.
F6, 1837, Nambusunhwan-ro, Gwanak-gu, Seoul, 08738, Republic of Korea